CAPZA2

capping actin protein of muscle Z-line subunit alpha 2, the group of Dynactin subunits

Basic information

Region (hg38): 7:116811070-116922049

Links

ENSG00000198898NCBI:830OMIM:601571HGNC:1490Uniprot:P47755AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • complex neurodevelopmental disorder (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CAPZA2 gene.

  • Intellectual disability (1 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAPZA2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
1
clinvar
9
clinvar
10
nonsense
2
clinvar
2
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
0
non coding
0
Total 1 0 13 0 0

Variants in CAPZA2

This is a list of pathogenic ClinVar variants found in the CAPZA2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-116862615-G-A Uncertain significance (Feb 01, 2024)3027222
7-116862629-GC-G Uncertain significance (Oct 12, 2023)3252957
7-116888139-G-A not specified Uncertain significance (Nov 21, 2022)2354326
7-116888155-A-C not specified Uncertain significance (Aug 19, 2023)2619485
7-116888181-G-A not specified Uncertain significance (Apr 13, 2022)2284096
7-116888184-T-G not specified Uncertain significance (Feb 08, 2023)2482445
7-116893005-C-G Uncertain significance (May 25, 2022)1806807
7-116893014-A-C not specified Uncertain significance (Dec 05, 2022)2332984
7-116893014-A-G See cases Uncertain significance (Oct 08, 2020)1690948
7-116893039-C-G Uncertain significance (Dec 12, 2023)3365680
7-116904346-C-T not specified Uncertain significance (Apr 16, 2024)3263278
7-116904379-G-A not specified Uncertain significance (Apr 18, 2024)3263279
7-116910274-C-A not specified Uncertain significance (Jan 29, 2024)3137264
7-116910312-G-T Uncertain significance (May 10, 2023)2662269
7-116910313-T-G Uncertain significance (Dec 21, 2022)2506832
7-116912102-G-A not specified Uncertain significance (May 01, 2023)2541305
7-116917772-A-G Intellectual disability Pathogenic (Mar 16, 2020)830217
7-116917781-C-T Likely pathogenic (Feb 17, 2024)3369411
7-116917782-G-T Intellectual disability Conflicting classifications of pathogenicity (Feb 16, 2022)830216
7-116917819-G-A Uncertain significance (Feb 27, 2023)2577676

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CAPZA2protein_codingprotein_codingENST00000361183 10110980
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9980.0017200000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.84861490.5760.000007581893
Missense in Polyphen740.8410.17139564
Synonymous1.563548.90.7160.00000244493
Loss of Function3.99018.60.008.50e-7230

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments.;
Pathway
Endocytosis - Homo sapiens (human);Vesicle-mediated transport;Membrane Trafficking;Factors involved in megakaryocyte development and platelet production;Post-translational protein modification;Metabolism of proteins;Innate Immune System;Immune System;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Hemostasis;COPI-independent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;COPI-mediated anterograde transport;Advanced glycosylation endproduct receptor signaling;ER to Golgi Anterograde Transport;Intra-Golgi and retrograde Golgi-to-ER traffic (Consensus)

Recessive Scores

pRec
0.221

Intolerance Scores

loftool
rvis_EVS
0.19
rvis_percentile_EVS
66.82

Haploinsufficiency Scores

pHI
0.524
hipred
Y
hipred_score
0.725
ghis
0.475

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.370

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Capza2
Phenotype
normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype;

Gene ontology

Biological process
endoplasmic reticulum to Golgi vesicle-mediated transport;blood coagulation;antigen processing and presentation of exogenous peptide antigen via MHC class II;actin cytoskeleton organization;innate immune response;barbed-end actin filament capping;protein-containing complex assembly
Cellular component
extracellular region;cytosol;brush border;F-actin capping protein complex;actin cytoskeleton;membrane;actin cortical patch;extracellular exosome
Molecular function
actin filament binding